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Introduction
LASER, despite its history, is recognized as a new technol-
ogy worldwide. Also, nanotechnology is one of the most 
recent fields of science. These two technologies, with their 
specific characteristics, have played a major role in medi-
cine and dentistry. Simultaneous use of these two tech-
nologies has created a new approach to modern medicine 
and dentistry, like diagnosis and treatment of cancer, drug 
releasing systems, rapid medical testing, tooth sensitivity 
treatment and improving the adhesion to tooth structure 
in dentistry.
Recent investigations showed that there has been an 
increase in the prevalence of cancers. According to 
GLOBACON (related to World Health Organization) 
there were about 12.7 million patients suffering from can-
cer worldwide in 2008 (excluding non-melanoma skin 
cancer) which is expected to reach 21 million by 2030. 
This increase requires new treatment methods to be de-
veloped.
Cancers are classified based on different aspects such as 
classification according to the cell origin. Carcinoma in-
cludes cancers originating from epithelial cells (e.g., epi-
thelial squamous cell cancer), or the cells that cover the 
internal organs (such as lung cancer) or glands (e.g. breast 
cancer). Sarcoma refers to cancer originating from mes-
enchymal tissues such as bone and muscle. Leukemia and 
lymphoma include cancers originating respectively from 
blood-forming and immune cells.1
Several methods have been used to treat cancers, includ-
ing surgery, chemotherapy, radiation therapy, etc. Now-
adays, with the recent advances in medical science and 
new technologies, novel methods have been introduced 
such as hormone therapy, photodynamic therapy (PDT), 
treatments using nanoparticles and eventually combin-
ations of lasers and nanoparticles. PDT depends on the 
availability of oxygen in tumours, but in methods using 
lasers and nanoparticles, there is no such limitation and 
they can be used as alternative methods.
Nano technology refers to work at the atomic, molecular 
and supra-molecular levels (scale of 1-100 nm) in order to 
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Abstract
Several methods have been employed for cancer treatment including surgery, chemotherapy 
and radiation therapy. Today, recent advances in medical science and development of 
new technologies, have led to the introduction of new methods such as hormone therapy, 
Photodynamic therapy (PDT), treatments using nanoparticles and eventually combinations 
of lasers and nanoparticles. The unique features of LASERs such as photo-thermal properties 
and the particular characteristics of nanoparticles, given their extremely small size, may 
provide an interesting combined therapeutic effect. The purpose of this study was to review 
the simultaneous application of lasers and metal nanoparticles for the treatment of cancers 
with epithelial origin. A comprehensive search in electronic sources including PubMed, 
Google Scholar and Science Direct was carried out between 2000 and 2013. Among the 
initial 400 articles, 250 articles applied nanoparticles and lasers in combination, in which 
more than 50 articles covered the treatment of cancer with epithelial origin. In the future, 
the combination of laser and nanoparticles may be used as a new or an alternative method 
for cancer therapy or diagnosis. Obviously, to exclude the effect of laser’s wavelength and 
nanoparticle’s properties more animal studies and clinical trials are required as a lack of 
perfect studies.
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                                                        Laser Therapy and Metal Nanoparticles in Cancer Treatment
understand, create and make use of materials, structures, 
devices and systems with fundamentally new properties 
and functions due to their small structure.2
Nanomaterials are classified based on various parameters 
including material, size (dimension), shape, etc. with each 
of them have different applications. Today, nanoparticles 
(which are the nanomaterial with 3 dimensions) with 
unique characteristics and tunable optical properties pro-
vide valuable cell therapy methods. Great progress has 
been made in the use of metal nanoparticles for biomed-
ical applications due to their unique size and shape prop-
erties.3-6 Among metallic nanoparticles, gold and silver 
nanoparticles are highly regarded with increased use in 
biomedical field.3,7,8
Nanoparticles are most widely used in the biomedical 
fields for diagnosis and treatment of cancer. Treatment of 
tumours surrounded by vital tissues is problematic and 
there is a probability that tumour margins remain unclear. 
On the other hand, cutting healthy tissues may lead to 
unacceptable beauty and medical results. Application of 
nanoparticles provides a high degree of accuracy. On the 
other side near infrared (NIR) radiation is an interesting 
energy source as human blood and body tissues have the 
minimum absorption in this wavelength, thus deeper tis-
sues can be reached.9
The unique features of lasers such as photo-thermal 
properties and the extremely small size of nanoparticles 
(which creates new physical effects that are mainly a re-
sult of domination of the quantum properties in contrast 
to classical properties), provide an interesting combined 
therapeutic effect. Thermal therapy procures a fast recov-
ery, shorter hospital stay, less complications and is easy to 
perform.10
There are a variety of nanoparticles, and each has its 
own unique properties and applications such as nanor-
ings, nanoshells, nanorods, nanopores and nanowires, 
etc. Depending on the peak absorption of nanoparticles, 
different lasers are used. For example researchers have 
investigated NIR-tunable nanostructures (nanoshells,11-13 
nanorods,14 and nanoclusters,13,15 etc) for photo-thermal 
functionality.16
In fact nanoparticles that have been synthesized to date, 
have the most absorption in the wavelength range of 
600-1200 nm (laser diode). In the future, nanoparticles 
with maximum absorption in other wavelengths may be 
synthesized. 
Liver, spleen and kidneys are sites that are most effected 
by nanoparticles.17 Morbidity and renal complication are 
the cause of use of gold nanoparticles modified with cer-
tain thiol monolayers such as tiopronin.18 Variable tox-
icity of nanoparticles is achieved through different size 
and the material which coats them. For example gluta-
thione-coated gold nanoparticles have 100% survival rate 
even at concentrations up to and including 60 μM.18 In-
vestigations show that nanoclusters with smaller size can 
effectively reduce their toxicity.17,19 The excretion of nano-
particle is through renal clearance.17
The aim of this study was the review of the literature in 
which lasers and nanoparticles were used simultaneously 
to treat cancers with epithelial origin.
Results
A thorough search in electronic sources Science Direct, 
PubMed, Google Scholar was performed for clinical arti-
cles between 2000 and 2013 with the following keywords 
“Au nanoparticle,” “Ag nanoparticle,” “Cancer therapy,” 
“Laser,” and “Combination of Au/Ag in cancer therapy.” 
Overall, 400 articles were found in relation to nanopar-
ticles and lasers topics, among which 250 articles used 
nanoparticles and lasers in combination while in more 
than 50 articles nanoparticles and laser were used togeth-
er in the treatment of cancer with epithelial origin. Most 
of these studies addressed breast cancer but could be ex-
tended to oral tumours.
After assessment of the articles, they have been categor-
ized into different groups based on the type of nanopar-
ticles used in combination with lasers.
Studies on Gold Nanoparticles (Au) Use in Combination 
With Laser
As mentioned above great progresses have been made in 
the use of metal nanoparticles especially gold. Because 
of their unique properties which depend on their size 
and shape, nanoparticles are used for medical purposes. 
Among different nanostructures gold nanoparticles are 
the most appropriate candidate in photothermal sensi-
tizing for the following reasons: they powerfully absorb 
laser light, are nontoxic, easily conjugates with proteins 
and antibodies and have tunable optical properties.3
Different types of nanoparticles were used in various ex-
periments which consisted of silica gold nanoshells, gold 
nanorods, gold nanocages, gold-gold sulfide nanopar-
ticles and hollow gold nanoshells. These nanoparticles 
have good absorption in NIR spectra which provides the 
most transformation and the least reflection of light in 
vital tissues. Transformation of nanoparticles can be done 
in a systemic way (through intravenous injection).9,10 
Many studies have been done in this field. 
In Vitro Studies
In 2012, Kuo et al evaluated dual-modality photodynamic 
therapy (PDT) and photothermal therapy (PTT) by gold 
nanomaterials conjugated with indocyanine green. Hu-
man lung carcinoma malignant cell line (A549) conjugat-
ed with AbEGFR-Au NP of different sizes were irradiated 
by 808-nm CW diode laser ([22.5 W/cm2], [20 W/cm2])
femtosecond and Ti:sapphire femtosecond laser (700 nm) 
at 2 mW for 10 minutes integration. PTT and PDT killed 
cancer cells in an efficient manner.20
Kessentini and Barchiesi compared quantitatively opti-
mized nanorods, nanoshells and hollow nanospheres for 
PTT. Several study groups consisting of shallow cancer 
(e.g. skin cancer) and deep cancer conjugated with dif-
ferent types of nanoparticles: (1) nanorods: (a) spheroid 
(b) cylinder (c) capped cylinder, (2) nanoshells, and (3) 
hollow nanospheres (different sizes). The samples were 
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exposed to pulsed laser (633 nm laser [shallow cancer] 
and 800 nm [deep cancer]). They found that the hollow 
nanospheres are more efficient for shallow cancer ther-
apy; whereas hollow nanospheres and nanorods, present 
similar absorption efficiencies for deep cancer therapy.21
In 2011, Fekrazad et al investigated the use of anti-HER2 
immuno-nanoshells in treatment of oral squamous cell 
carcinoma. HER2-positive KB cells and HER2-negative 
HeLaS3 were bound with gold-silica nanoshell conjugated 
with anti-her2 (100 nm) and then exposed to laser irradi-
ation at 810 nm and 4 W/cm2 for 2 minutes. Significant 
cell death in the KB tumour cell cultures was reported, 
while there was no evidence of cellular damage or death 
in the HeLaS3.22
Day et al23 investigated the diagnosis and treatment of 
cancer by antibody-conjugated gold-gold sulfide nano-
particles. SK-BR-3 breast carcinoma conjugated with ant-
ti-HER2 antibodies conjugated GGS-NPs was exposed to 
an 800 nm pulsed laser, consisting of low laser powers (1 
mW) for making image and high laser powers (50 mW) 
for inducing cancerous cells to death. Regarding this 
study, imaging and therapeutic capability of nanoparticles 
depended on the amount of laser power.23 Other studies 
in this area have been summarized in Table 1. 
Animal Studies
Considering the positive results of several in vitro studies, 
researchers have continued their work on animal models. 
In 2012, Ma et al showed that Au capped magnetic core/
mesoporous silica shell nanoparticles have a synergistic 
influence of mixed chemo- and photo-thermo therapy. 
Human breast cancer MCF-7 cells which were seeded in 
96-well plate were exposed to 808 nm high power multi-
mode pump laser at a power density of 2.0 W/cm2 with a 
beam diameter of 5 mm for 5 minutes. A synergistic effect 
in loosing viability of cancer cells was reported. They also 
evaluated this effect in an in vivo study. Walker 256 cells 
were implanted into SD mice and Au NRs were injected 
into the tumours under anaesthesia. Then the mice were 
irradiated by 808 nm high power multimode pump laser 
(beam diameter of 5 mm and power density of 2.0 W cm-2) 
for 5 minutes. They could lower the dosage of anti-cancer 
drug through the synergistic effect, so the toxicity of the 
drug was limited.25
In 2011, Xie et al showed that Integrin αvβ3-targeted gold 
nanoshells increase tumour vasculature-specific imaging 
and therapy. HNSCC cell line SCC-4 were inoculated 
subcutaneously in nude rats for PET imaging for setting 
up an HNSCC xeno graft model. Then 64Cu-NS–RGD-
fK was injected into the rats’ tail veins and PET imaging 
was done. For thermoablation analysis the subcutaneous 
colorectal cancer xeno graft was performed in nude mice, 
using HCT116 human tumour cells. Then, NS–PEG5K 
and NS–RGDfK solutions were injected via the tail vein 
(in each group 2 mice) and mice were exposed to 808 nm 
NIR laser light with a spot size of 1 cm and 1.2 W 75% 
duty cycle. Improvement of tumour targeting by conjuga-
tion of NSs to cyclo (RGDfK) was seen in all test groups. 
However, more tumour necrosis was observed in subabla-
tive group.49 Similar studies are summarized in Table 2. 
Accordingly, it can be concluded that gold nanoparticles 
and lasers can be used in the treatment of cancer.
Studies Using Silver Nanoparticles (Ag) in Combination 
With Laser
Prominent for their antibacterial and wound healing be-
haviour, silver nanoparticles have lately made their way 
into cancer therapies.65 When tested on living cells, they 
were captivatingly shown to have dual activity, inhibiting 
the growth and the division of tumour cells and their nu-
clei, while being biocompatible for the healthy ones.66,67 
Further recent results exemplify that silver nanoparticles 
with different sizes could enhance magnetic induced ther-
mo-sensitivity of glioma cells depending on their size.68
In Vitro Studies
In 2011, Boca et al investigated chitosan-coated triangu-
lar silver nanoparticles as a novel set of biocompatible 
and very effective photo-thermal transducers for in vitro 
cancer cell treatment. In this study they reported the 
performance of newly synthesized chitosan-coated sil-
ver nano-triangles (Chit-AgNTs) with strong resonances 
in NIR to operate as photo-thermal agent against a line 
of human non-small lung cancer cells (NCI-H460). The 
results revealed a novel class of biocompatible plasmon-
ic nanoparticles with high potential to be implemented 
as effective phototherapeutic agent in the battle against 
cancer.65 As these studies (Table 3) show, silver nanopar-
ticles are effective in cancer therapy.
Combination of Au/Ag
Only two papers have discussed the application of laser 
with a combination of silver and gold nanoparticles, prob-
ably because of the similar advantages of both elements. 
In 2008, Huang et al investigated the effect of selective 
PTT on mixed cancer cells, using aptamer-conjugated 
nanorods. To reach this aim they designed an aptam-
er-based nanoparticle, which could treat targeted cancer 
cell selectively and efficiently. They also showed that in 
contrast with other nanomaterials such as gold nanorods 
or nanoshells which need high power of laser irradiation, 
this combination of Au-Ag nanorods requires less laser 
irradiation to induce cell death in cancerous tissues.71
In 2008, Hu et al investigated core-free nano structured 
AuxAg1-x dendrites as a new therapeutic agent in treatment 
of cancer. Two types of Au0.3Ag0.7 and Au0.06Ag0.94 capped 
with anti-EGFR antibodies were used in this study. They 
both showed good biocompatibility. After irradiating mac-
lignant lung cancer cells A549 with NIR laser (800 nm), 
cell viability reduced dramatically in cultures treated by 
anti-EGFR conjugated with Au0.3Ag0.7 dendrites, while the 
laser power was in the range of 10–15 W cm-2.72 Other 
similar studies have been summarized in Table 4.
Discussion
The combination of nanoparticles and laser therapy elim-
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inates cancer cells via two mechanisms. First, there are a 
series of specific molecules such as HER2, ERBB1 on the 
surface of cancer cells. Initially, antibodies against these 
molecules are designed, and then nanoparticles are bind 
to these antibodies. These nanoparticles attached to the 
antibody and then to the cell surface molecules. The tu-
mour area is irradiated with a laser, which has most ab-
sorption in nanoparticles. Laser irradiation causes heat in 
the gold or silver area and the total heat leads to the se-
lective death of cancer cells. Such mechanism, which can 
target cancer cells selectively, is not seen in other methods 
such as chemotherapy and surgery. In fact, this is the ad-
vantage of such mechanism.22,37,39,65 
In the second mechanism murine macrophage is used and 
it is labeled with cell fluorescent dye PKH26GLred. Then 
gold nanoshells are loaded to the macrophages under 710 
to 820 nm light and the tumour/macrophage hybrid is 
produced by centrifusion. Afterwards, the hybrid is ir-
radiated with 810 nm laser with the power density of 2- 28 
W/cm2. Laser light not only destroys the macrophages but 
is also toxic to the surrounding cells.27 
A brief survey shows that no study has been done on 
humans and most of the studies have been done in vitro 
and some of them on animals. The reason might be lim-
ited volunteer patients, and the fact that this method is a 
complicated and novel science. Studies also showed that 
in treatment of cancer cells the most used nanoparticle 
are gold (Au) and silver (Ag) nanoparticles or to a less-
er extent, a combination of gold and silver nanoparticles. 
Besides, the highest laser wavelength is in the visible and 
NIR range (400-1200 nm), so the outcome is related to the 
optical properties of the biological tissues.
In all in vitro and animal studies, the result of combined 
use of nanoparticle and laser for therapeutic purposes was 
the death of cancerous cells and enhancement of tumour 
contrast for imaging intentions.3,7,25,38,48
The type of Laser applied in most of the investigations 
was NIR with wavelength spectra of 785 nm up to 1046 
nm,4,7,10,15,21,39,40,56,59 with 808 nm wavelength used more 
frequently.10,20,25,29,34,41,49,62,72 As mentioned earlier, the 808 
nm wavelength was the most effective in studies aiming at 
photothermal destruction of cancer cells. The absorption 
peak of gold nanoparticles can be modulated by creating 
different shapes and size.73,74
Another investigated wavelength was in the visible light 
spectra: 420 nm up to 690 nm.3,15,21,33,35,38,46,56,70 The app-
plication of this wavelength was mostly in generating 
nanobubbles15,33,35,38,46 and destruction of cancer cells in 
nanocomposites system.21,56 Nd:YAG, Diode laser and 
Ti:sapphire were such systems. Samples were chosen from 
epithelial carcinomas including: A431,3,54 lung carcinoma 
cells (A549),20,33,35,72 glioblastoma,7 SK-BR-34,34,39,40,48 and 
other carcinomas occurring in epithelial tissues. Nano-
particles included gold silica nanoshells,21,22,27,41,43,48,49 gold 
nanoparticles,15,20,46 triangular silver nanoparticles, hollow 
gold nanospheres,21,44,54,62 silver dendrimer nanocompos-
ites,70 gold nanorods,10,20,21 AuxAgx,
72 gold nanocages39 and 
gold nanocomposites.25,29,38,40,56
Fekrazad et al
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Table 3. Ag Nanoparticles (In Vitro Studies)






2 W, 808 nm laser
power density of 1.4 
W cm-2
Mean diameter of 83 nm
silica-coated plasmonic Pd@
Ag core-shell nanoplates
Plasmonic Pd@Ag Core-Shell 
Bimetallic Nanoplates
~ 100% of the liver cancer 
cells were killed after irradiation for 5 min with 
an 808 nm 
laser providing a power density of 1.4 W cm-2 
+










Biocompatible plasmonic nanoparticles with 
high potential to be implemented as effective 











Three different average 
laser powers: 1.2 mW, 
0.6 mW, and 0.12 mW.
Silver-dendrimer composite 
nanodevices (CNDs) CNDs 
[(Ag(0))(25)-PAMAM_
E5.(NH(2))(42)(NGly)(74)(NFA)
(2.7)] dendrimer-folic acid (FA) 
conjugates
Significant reduction in breakdown threshold 
and thus selectively promoting intracellular laser-
induced optical breakdown.
+
Table 4. Combination of Ag & Au Nanoparticles  (In Vitro Studies)
Author/Year Target Cells Laser Characteristics Nanoparticle Characteristics Results 
Huang et al 
(2008)71 (NB-4) cells
8.5 x 10 (4) W/m (2) 
laser exposure Au-Ag NRs
Au-Ag nanorod combination offers 
selective and efficient photothermal 
killing of targeted tumour cells.
The tumour tissue will be selectively 
destroyed at laser energies which will 
not harm the surrounding normal tissue.
+
Hu et al 
(2008)72
SK-BR-3 (Her2/neu-
positive breast cancer 
cells) and H520 (Her2/
neu-negative lung cancer 
cells) cells
NIR region 800 nm




Ag(1-x) nanostructures with 
dendrite morphology and 
a hollow interior dendrites 
400 nm
The hollow Au0.3Ag0.7 nano structured 
dendrites show potential in photo 
thermolysis for killing cancer cells.
+
Antibodies anti-HER2, anti-EGFR were used the 
most to conjugate with nanoparticles and acts as 
nanocarriers.3,34,35,39,40 
Some studies used macrophages as biocarriers of nano-
particles, through phagocytosis.7,27 The main tasks of 
macrophages are to overwhelm and digest alien material 
of the body, so they easily move due to their migration 
capability and can simply surround cancer tumours. Be-
sides macrophages are exceedingly located inside and 
around cancer tumours, while some studies show that up 
to 30% of cancer tumours consist of macrophages.7,27 
Most studies used gold as the only nanoagents. These 
nanoparticles powerfully absorb laser light, are nontoxic, 
easily conjugates with proteins and antibodies, and have 
tunable optical properties.3 Two studies focused their in-
vestigations only on silver nanoparticles65,70 that were also 
effective in cancer therapy, but no study compared gold 
only and silver only nanoparticles with each other. Two 
studies investigated the combination of gold and silver as 
a unit agent,71,72 which showed better performance than 
gold alone.
Disadvantages of lasers and nanoparticles combined 
therapy include high cost and difficulty finding identical 
particles. Besides, it requires complicated and advanced 
technology which may not be easily obtained.
Conclusion
It can be concluded that laser and nanoparticles together 
are a novel class of cancer therapy and diagnosis. More 
studies should be done to identify the most effective 
nanoparticles and laser wavelength. Also, more animal 
studies and clinical trials need to be done as mandated by 
the lack of valid enough studies in this field.
These methods and mechanisms can be used as a treat-
ment modality to aid cure cancers in future.
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